Literature DB >> 3339169

Determination of left-sided pressure gradients by utilizing Doppler aortic and mitral regurgitant signals: validation by simultaneous dual catheter and Doppler studies.

R A Nishimura1, A J Tajik.   

Abstract

Continuous wave Doppler echocardiography is an accurate and reproducible method for determination of intracardiac pressure gradients in stenotic valve lesions and right-sided regurgitant lesions. Twenty-three patients with either mitral or aortic regurgitation underwent simultaneous continuous wave Doppler and dual catheter pressure recordings to determine if instantaneous pressure gradients can be accurately determined by Doppler ultrasound in left-sided regurgitant valve lesions. Using the modified Bernoulli equation, the maximal and mean pressure gradients between the left ventricle and left atrium were determined by continuous wave Doppler ultrasound in patients with mitral regurgitation and compared with simultaneous catheter-derived pressures. The mean and end-diastolic pressure gradients between the aorta and left ventricle were determined by continuous wave Doppler ultrasound in patients with aortic regurgitation and compared with simultaneous catheter-derived pressures. Diastolic half-times by both continuous wave Doppler ultrasound and catheter pressures were compared in patients with aortic regurgitation. There was a linear correlation between the mean gradients in all patients (r = 0.94; SEE = 6 mm Hg) with a similar correlation between the instantaneous gradients (r = 0.98; SEE = 8 mm Hg). There was a linear correlation between diastolic half-times by catheter and Doppler ultrasound (r = 0.95; SEE = 39 ms). As with other valvular lesions, continuous wave Doppler echocardiography can be used in patients with mitral or aortic regurgitation to accurately determine intracardiac pressure gradients.

Entities:  

Mesh:

Year:  1988        PMID: 3339169     DOI: 10.1016/0735-1097(88)90096-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Echocardiographic assessment of left ventricular systolic function: from ejection fraction to torsion.

Authors:  Matteo Cameli; Sergio Mondillo; Marco Solari; Francesca Maria Righini; Valentina Andrei; Carla Contaldi; Eugenia De Marco; Michele Di Mauro; Roberta Esposito; Sabina Gallina; Roberta Montisci; Andrea Rossi; Maurizio Galderisi; Stefano Nistri; Eustachio Agricola; Donato Mele
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

Review 2.  [Assessment of systolic function in patients with poor echogenicity: echocardiographic methods].

Authors:  F Weidemann; D Liu; M Niemann; S Herrmann; H Hu; P D Gaudron; G Ertl; K Hu
Journal:  Herz       Date:  2013-08-15       Impact factor: 1.443

Review 3.  Two-dimensional and Doppler echocardiography for the assessment of congestive heart failure.

Authors:  S Wilansky
Journal:  Tex Heart Inst J       Date:  1998

4.  Dynamic on-line quantification of biventricular function with acoustic quantification (AQ). Validation, reproducibility and normal values of a new echocardiographic approach.

Authors:  B Hausmann; S Muurling; R Simon
Journal:  Int J Card Imaging       Date:  1997-12

5.  Relation of Transthoracic Echocardiographic Aortic Regurgitation to Pressure Half-time and All-Cause Mortality.

Authors:  Jordan B Strom; Eli V Gelfand; Lawrence J Markson; Connie A Tsao; Warren J Manning
Journal:  Am J Cardiol       Date:  2020-08-28       Impact factor: 2.778

6.  Doppler reconstruction of left ventricular pressure from functional mitral regurgitation: potential importance of varying orifice geometry.

Authors:  H B Xiao; X Y Jin; D G Gibson
Journal:  Br Heart J       Date:  1995-01

7.  Performance of the Hypotension Prediction Index with non-invasive arterial pressure waveforms in non-cardiac surgical patients.

Authors:  Kamal Maheshwari; Sai Buddi; Zhongping Jian; Jos Settels; Tetsuya Shimada; Barak Cohen; Daniel I Sessler; Feras Hatib
Journal:  J Clin Monit Comput       Date:  2020-01-27       Impact factor: 2.502

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.